August 2020 – Proactive Investors: One2One Virtual Conference

https://youtu.be/HjMglJPChJA

Preliminary Results Presentation for the year ended 31 March 2020

To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.

Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation

To view the presentation please click here…

Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’

https://youtu.be/ADBu4Uy7ZZ0

OIS: Ophthalmology Innovation & Investment – ReNeuron using hRPCs to treat inherited retinal degenerative diseases

CEO Presents at Cell & Gene Investor Day, April 2017, Boston

Proactive Investors : CFO ‘pleased’ with reformulation of degenerative diseases treatment

To view the full article click here…

CFO Michael Hunt Presents at Shares Magazine Investor Evening – 27th October 2016

CEO Presents at the 6th Annual Cell & Gene Partnering Forum on the Mesa 2016

CFO comments on publication of positive pre-clinical data fron retinitis pigmentosa programme

https://youtu.be/Czkrxhc2ako